KLBF:IDX
Kalbe Farma Tbk PT
725,00 IDR
arrow_upward
+0,69%(+5,00) 1G
2 ott, 16:13:52 GMT+7 · IDR
search
Tutti i simboli
| Simbolo | Prezzo | Cambio | % di cambio |
|---|
insights_autoGenerazione degli insight principali per KLBF in corso…
Apertura
725 IDR
Massimo
735 IDR
Minimo
715 IDR
Cap. mercato
33,94 Bln
Vol. medio
71,19 Mln
Volume
22,72 Mln
Dividendo
2,76%
Dividendo trimestrale
5 IDR
Data di stacco dividendo
4 giu 2026
Rapporto P/E
9,11
Max 52 sett.
1.345 IDR
Min 52 sett.
630 IDR
Utili per azione
80 IDR
Azioni in circolazione
46,81 Mld
N. di dipendenti
13K
Apertura
725 IDR
Massimo
735 IDR
Minimo
715 IDR
Cap. mercato
33,94 Bln
Vol. medio
71,19 Mln
Volume
22,72 Mln
Dividendo
2,76%
Dividendo trimestrale
5 IDR
Data di stacco dividendo
4 giu 2026
Rapporto P/E
9,11
Max 52 sett.
1.345 IDR
Min 52 sett.
630 IDR
Utili per azione
80 IDR
Azioni in circolazione
46,81 Mld
N. di dipendenti
13K
Articoli giornalistici
Da fonti web e partner giornalistici
AD HOC NEWS
·
14 ore fa
Kalbe Farma cancels IDR 500 billion buyback of Kalbe Farma stock
Profilo
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Informazioni su Kalbe Farma Tbk PT